Literature DB >> 8862081

Octreotide diminishes luminal nutrient transport activity, which is reversed by epidermal growth factor.

A S Seydel1, J H Miller, T P Sarac, C K Ryan, W Y Chey, H C Sax.   

Abstract

BACKGROUND: Octreotide (SMS) is a somatostatin analogue utilized in patients with short bowel syndrome (SBS) to decrease output. It may inhibit small bowel adaptation by blocking the secretion of trophic hormones such as epidermal growth factor (EGF). This study delineates the effects of SMS and EGF on nutrient transport in SBS.
METHODS: One week after 70% jejunoileal resection, 20 New Zealand White rabbits (2 kg) received subcutaneous infusions of saline or EGF (1.5 micrograms/kg/hr) and injections of saline or SMS s.q.b.i.d. The study groups were EGF/saline, saline/saline, saline/SMS, and EGF/SMS. After 7 days of infusion, intestinal brush border membrane vesicles were prepared and nutrient transport measured.
RESULTS: SMS reduced active nutrient transport. Kinetics confirmed this was secondary to a reduction in functional carriers in the brush border membrane, without a change in carrier affinity. The coinfusion of EGF ameliorated this effect. On an individual basis, EGF alone did not significantly increase nutrient transport, but when taken as a group, nutrients transport was upregulated 26%.
CONCLUSIONS: SMS is detrimental to small bowel adaptation. EGF reverses this effect and may benefit patients with SBS who require SMS to control high intestinal output.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862081     DOI: 10.1016/s0002-9610(96)00163-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Epidermal growth factor receptor is increased in rabbit intestinal brush border membrane after small bowel resection.

Authors:  N E Avissar; H T Wang; J H Miller; P Iannoli; H C Sax
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Epidermal growth factor and neurotensin induce microvillus hypertrophy following massive enterectomy.

Authors:  C K Ryan; J H Miller; A S Seydel; K de Mesy Jensen; H C Sax
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

Review 3.  Novel therapies for the management of short bowel syndrome in children.

Authors:  Marshall Z Schwartz
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.